Drug Trial Radar · NCT02016560
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
Last checked: Nov 19, 2026Latest source record: Sep 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
383
Actual
Start
Dec 2013
Primary completion
Jul 28, 2017
Study completion Jul 28, 2017
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Dec 20, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Phase 2/3 cross-sectional and longitudinal observational study evaluating imaging characteristics of flortaucipir in control subjects and patients with clinically defined MCI and AD dementia (AD).
Conditions
- Alzheimer's Disease
Interventions
florbetapir F 18Drug
Flortaucipir F18Drug
Brain PET ScanProcedure
positron emission tomography (PET) scan of the brain
Primary outcomes
What the sponsor says the trial is designed to measure.
- Confirmatory Phase: Relationship Between Neocortical Flortaucipir Uptake and the Subsequent Rate of Cognitive DeclineTime frame: between baseline and 18 months
- Exploratory Phase: Cross-sectional Flortaucipir Imaging ResultsTime frame: baseline scan
- Exploratory Phase: Longitudinal Change in Tau Deposition Over Time, by Amyloid StatusTime frame: baseline and 18 months
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Banner Alzheimer's Institute
Phoenix, Arizona
Four Peaks Neurology
Scottsdale, Arizona
Mayo Clinic
Scottsdale, Arizona
Banner Sun Health Research Institute
Sun City, Arizona
UC Irvine
Irvine, California
Hoag Memorial
Newport Beach, California
Norther California PET Imaging Center
Sacramento, California
UC Davis
Sacramento, California
UC San Francisco
San Francisco, California
Neurological Research Institute
Santa Monica, California
Molecular NeuroImaging
New Haven, Connecticut
Quantum Laboratories
Deerfield Beach, Florida
21st Century Oncology
Fort Myers, Florida
Sandlake Imaging
Orlando, Florida
Meridien Research
St. Petersburg, Florida
USF Health Byrd Alzheimer's Center
Tampa, Florida
Independent Imaging
West Palm Beach, Florida
Massachusetts General Hospital
Boston, Massachusetts
Boston University
Boston, Massachusetts
Alzheimer's Disease Center
Quincy, Massachusetts
Center for Clinical Imaging Research
St Louis, Missouri
Las Vegas Radiology
Las Vegas, Nevada
Center for Brain Health - NYU Langone Medical Center
New York, New York
Duke University Medical Center
Durham, North Carolina
University of Pennsylvania
Philadelphia, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
Butler Hospital
Providence, Rhode Island
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.